P Johansson1, Ö Dahlström, U Dahlström, U Alehagen. 1. Peter Johansson, RN, PhD, Department of Cardiology, University Hospital of Linköping, SE-581 85 Linköping, E-mail: peter.johansson@aries.vokby.se.
Abstract
BACKGROUND: The impact of supplementation with selenium and coenzyme Q10 (CoQ10) on health-care usage and health-related quality of life (Hr-QoL) in community-dwelling elderly people has, to our knowledge, not previously been investigated. AIM: To investigate the effect of 48 months supplementation with CoQ10 and selenium on community-dwelling elderly as regards: (I) the number of days out of hospital, and (II) the effect on Hr-QoL. METHODS: A 48-month double-blind randomized placebo-controlled trial was carried out. A total of 443 participants were givenCoQ10 and organic selenium yeast combined, or a placebo. All admissions to the Department of Internal Medicine or Cardiology were evaluated. Hr-QoL were measured with the Short Form-36 (SF-36), the Cardiac Health Profile (CHP) and one item overall-quality of life (overall-QoL). RESULTS:A total of 206 participants were evaluated after 48 months. No changes were found in the number of days out of hospital or Hr-QoL. A sub-analysis of participants matched for age, gender and baseline cardiac wall tension as measured by NT-proBNP was performed. The mean number of days out of hospital was 1779 for those taking the active substance compared to 1533 for those taking the placebo (p=0.03). Those with active substance declined significantly less in the HR-QoL domains of physical role performance (p=0.001), vitality (p=0.001), physical component score (p=0.001), overall QoL (p=0.001), somatic dimension (p=0.001), conative dimension (p=0.001) and global function (p=0.001). CONCLUSION: In a match-group analysis selenium and CoQ10 increased the number of days out of hospital and slowed the deterioration in Hr-QoL.
RCT Entities:
BACKGROUND: The impact of supplementation with selenium and coenzyme Q10 (CoQ10) on health-care usage and health-related quality of life (Hr-QoL) in community-dwelling elderly people has, to our knowledge, not previously been investigated. AIM: To investigate the effect of 48 months supplementation with CoQ10 and selenium on community-dwelling elderly as regards: (I) the number of days out of hospital, and (II) the effect on Hr-QoL. METHODS: A 48-month double-blind randomized placebo-controlled trial was carried out. A total of 443 participants were given CoQ10 and organic seleniumyeast combined, or a placebo. All admissions to the Department of Internal Medicine or Cardiology were evaluated. Hr-QoL were measured with the Short Form-36 (SF-36), the Cardiac Health Profile (CHP) and one item overall-quality of life (overall-QoL). RESULTS: A total of 206 participants were evaluated after 48 months. No changes were found in the number of days out of hospital or Hr-QoL. A sub-analysis of participants matched for age, gender and baseline cardiac wall tension as measured by NT-proBNP was performed. The mean number of days out of hospital was 1779 for those taking the active substance compared to 1533 for those taking the placebo (p=0.03). Those with active substance declined significantly less in the HR-QoL domains of physical role performance (p=0.001), vitality (p=0.001), physical component score (p=0.001), overall QoL (p=0.001), somatic dimension (p=0.001), conative dimension (p=0.001) and global function (p=0.001). CONCLUSION: In a match-group analysis selenium and CoQ10 increased the number of days out of hospital and slowed the deterioration in Hr-QoL.
Authors: Samuli I Saarni; Jaana Suvisaari; Harri Sintonen; Seppo Koskinen; Tommi Härkänen; Jouko Lönnqvist Journal: J Clin Epidemiol Date: 2007-07-25 Impact factor: 6.437
Authors: Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg Journal: Eur J Heart Fail Date: 2008-09-16 Impact factor: 15.534
Authors: Svend A Mortensen; Franklin Rosenfeldt; Adarsh Kumar; Peter Dolliner; Krzysztof J Filipiak; Daniel Pella; Urban Alehagen; Günter Steurer; Gian P Littarru Journal: JACC Heart Fail Date: 2014-10-01 Impact factor: 12.035
Authors: Mehmet Seneş; Ali Riza Erbay; F Meriç Yilmaz; B Ciğdem Topkaya; Oğuzhan Zengi; Mehmet Doğan; Doğan Yücel Journal: Clin Chem Lab Med Date: 2008 Impact factor: 3.694
Authors: Jennifer Lee; Yeon Sik Hong; Jeong Hee Jeong; Eun Ji Yang; Joo Yeon Jhun; Mi Kyoung Park; Young Ok Jung; Jun Ki Min; Ho Youn Kim; Sung Hwan Park; Mi-La Cho Journal: PLoS One Date: 2013-07-22 Impact factor: 3.240
Authors: Tareq Al Saadi; Yazan Assaf; Medhat Farwati; Khaled Turkmani; Ahmed Al-Mouakeh; Baraa Shebli; Mohammed Khoja; Adib Essali; Mohammed E Madmani Journal: Cochrane Database Syst Rev Date: 2021-02-03
Authors: Jan Aaseth; Jan Alexander; Geir Bjørklund; Knut Hestad; Petr Dusek; Per M Roos; Urban Alehagen Journal: Biometals Date: 2016-08-16 Impact factor: 2.949
Authors: Urban Alehagen; Peter Johansson; Jan Aaseth; Jan Alexander; Izabella Surowiec; Katrin Lundstedt-Enkel; Torbjörn Lundstedt Journal: Biomolecules Date: 2019-09-30
Authors: Marcelo T Holanda; Mauro F F Mediano; Alejandro M Hasslocher-Moreno; Beatriz M S Gonzaga; Anna Cristina C Carvalho; Roberto R Ferreira; Luciana R Garzoni; Fernanda S Pereira-Silva; Luis O Pimentel; Marcelo O Mendes; Marcos J Azevedo; Constança Britto; Otacilio C Moreira; Alice G Fernandes; Carolina M Santos; Jéssica Constermani; Vitor B Paravidino; Erica R Maciel; Fernanda M Carneiro; Sérgio S Xavier; Gilberto M Sperandio da Silva; Priscila F Santos; Henrique H Veloso; Pedro E A A Brasil; Andrea S de Sousa; Maria G Bonecini-de-Almeida; Paula S da Silva; Luiz Henrique C Sangenis; Roberto M Saraiva; Tania C Araujo-Jorge Journal: EClinicalMedicine Date: 2021-08-28